Startseite Crystal structure of (E)-2-(5-(4-fluorophenyl)-3-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-5-((4-fluorophenyl)diazenyl)-4-methylthiazole, C23H17F2N5OS
Artikel Open Access

Crystal structure of (E)-2-(5-(4-fluorophenyl)-3-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-5-((4-fluorophenyl)diazenyl)-4-methylthiazole, C23H17F2N5OS

  • Gamal A. El-Hiti ORCID logo EMAIL logo , Bakr F. Abdel-Wahab , Amany S. Hegazy und Benson M. Kariuki
Veröffentlicht/Copyright: 18. März 2017
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 232 Heft 3

Abstract

C23H17F2N5OS, monoclinic, P21/c (no. 14), a = 5.2272(4) Å, b = 26.7398(15) Å, c = 15.2645(10) Å, β = 97.726(7)°, V = 2114.2(2) Å3, Z = 4, Rgt(F) = 0.0547, wRref(F2) = 0.1371, T = 296(2) K.

CCDC no.:: 1533011

The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Orange needle
Size:0.82 × 0.27 × 0.06 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:2.0 cm−1
Diffractometer, scan mode:SuperNova, ω-scans
2θmax, completeness:59.4°, >84% ( 99% to 50.4 2θ)
N(hkl)measured, N(hkl)unique, Rint:10634, 5088, 0.031
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3027
N(param)refined:290
Programs:CrysAlisPRO [14], SHELX [15], PLATON [16]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C10.6495(5)0.04738(10)0.59780(18)0.0655(7)
H10.77440.02240.60590.079*
C20.6361(5)0.08585(10)0.65183(18)0.0649(7)
H20.74730.09260.70330.078*
C30.4207(5)0.11438(10)0.61618(17)0.0615(7)
H30.36170.14360.63960.074*
C40.3163(5)0.09110(8)0.54141(15)0.0500(6)
C50.0979(5)0.10124(8)0.47659(15)0.0484(5)
C6−0.0673(5)0.14694(9)0.47670(16)0.0561(6)
H6A0.03590.17720.47970.067*
H6B−0.16760.14650.52570.067*
C7−0.2426(5)0.14272(8)0.38738(15)0.0511(6)
H7−0.42420.14550.39630.061*
C8−0.1805(4)0.18103(8)0.32111(15)0.0474(5)
C9−0.3144(5)0.22552(9)0.31469(19)0.0663(7)
H9−0.44750.23060.34850.080*
C10−0.2526(8)0.26247(12)0.2587(3)0.0966(13)
H10−0.34310.29250.25420.116*
C11−0.0596(9)0.25460(16)0.2104(2)0.1000(14)
C120.0778(7)0.21132(16)0.21420(19)0.0889(11)
H120.21060.20700.18000.107*
C130.0149(5)0.17366(10)0.27052(16)0.0610(7)
H130.10490.14360.27390.073*
C14−0.3075(5)0.06521(8)0.29387(15)0.0510(6)
C15−0.4537(5)0.00457(9)0.18424(16)0.0521(6)
C16−0.5903(5)0.04815(9)0.17850(16)0.0534(6)
C17−0.8163(5)0.05989(11)0.11044(18)0.0706(8)
H17A−0.96590.06580.13910.106*
H17B−0.84850.03220.07050.106*
H17C−0.77910.08920.07800.106*
C18−0.3962(5)−0.11526(9)0.09743(16)0.0549(6)
C19−0.6020(6)−0.12125(11)0.0320(2)0.0775(9)
H19−0.7214−0.09560.01980.093*
C20−0.6318(7)−0.16490(13)−0.0153(2)0.0914(10)
H20−0.7712−0.1691−0.05940.110*
C21−0.4549(6)−0.20178(11)0.00311(19)0.0728(8)
C22−0.2510(6)−0.19752(11)0.0663(2)0.0793(9)
H22−0.1328−0.22350.07770.095*
C23−0.2219(6)−0.15362(11)0.1137(2)0.0751(8)
H23−0.0816−0.14990.15760.090*
N10.0261(4)0.07057(7)0.41315(13)0.0538(5)
N2−0.1851(4)0.09153(7)0.36206(13)0.0564(5)
N3−0.5072(4)0.08338(7)0.24102(13)0.0548(5)
N4−0.5024(4)−0.03614(8)0.13060(13)0.0567(5)
N5−0.3458(4)−0.07204(8)0.15071(13)0.0579(5)
O10.4563(3)0.04935(6)0.52908(11)0.0641(5)
F10.0032(6)0.29140(10)0.15608(16)0.1654(13)
F2−0.4863(4)−0.24579(7)−0.04261(13)0.1111(7)
S1−0.20373(13)0.00572(2)0.27253(4)0.0553(2)

Source of material

The title compound was synthesized from reaction of a mixture of 1:1 molar ratios of 5-(4-fluorophenyl)-3-(furan-2-yl)-4,5-dihydro-1H-pyrazole-1-carbothioamide and N′-(4-fluorophenyl)-2-oxopropanehydrazonoyl chloride in ethanol under reflux condition for 2 h. The solid obtained on cooling was recrystallized from dimethylformamide to give the title compound as orange crystals in 64% yield, Mp. 225–226 °C [1].

Experimental details

All hydrogen atoms were placed in calculated positions and refined using a riding model. Methyl, methylene and methine C—H bonds were fixed at 0.96 Å, 0.97 Å and 0.98 Å respectively. Displacement parameters were 1.5 times Ueq(C) for methyl groups and 1.2 times Ueq(C) for methylene and methine hydrogens. Methyl groups were allowed to spin about the C—C bond. Aromatic C—H distances were set to 0.93 Å and their Uiso set to 1.2 times Ueq(C).

Discussion

Many pyrazolylthiazoles have been synthesized using different procedures and showed antinociceptive, anti-inflammatory and antimicrobial activities [2], [3], [4], [5], [6], [7], [8], [9], [10]. The X-ray crystal structures for related compounds have been published recently [11, 12].

The asymmetric unit consists of one molecule. In the molecule, the furan(A)-pyrazole(B)-thiazole(C)-fluorophenyl(D) ring system is almost planar. Thus the largest deviation from the least-squares plane through the four rings is 0.22(1) Å (by O1). The greatest difference between the planes through adjacent rings (A and B) is 7.1(2)°. The second fluorophenyl group (E) is almost perpendicular (85.0(5)°) to the A—B—C—D system. In the crystal, pairs of molecules related by an inversion centre interact through two edge-to-face interactions involving rings D and E with centroid-to-centroid distances of 5.3 Å. A short intermolecular O⋯O contact (2.84 Å) occurs between furan moieties of pairs of molecules related by inversion symmetry. Such contact is not unique, as shown by a search of the CSD [13] which gave 78 hits for contacts within the sum of van-der-Waals radii for furan oxygens.

Acknowledgement

The project was supported by King Saud University, Deanship of Scientific Research, Research Chair.

References

1 Abdel-Wahab, B. F.; Sediek, A.; Mohamed, H. A.; Awad, G. E. A.: Novel 2-pyrazolin-1-ylthiazoles as potential antimicrobial agents. Lett. Drug Design Discov. 10 (2013) 111–118.10.2174/157018013804725143Suche in Google Scholar

2 Prokopp, C. R.; Rubin, M. A.; Sauzem, P. D.; de Souza, A. H.; Berlese, D. B.; Lourega, R. V.; Muniz, M. N.; Bonacorso, H. G.; Zanatta, N.; Martins, M. A.; Mello, C. F.: A pyrazolyl-thiazole derivative causes antinociception in mice. Braz. J. Med. Biol. Res. 39 (2006) 795–799.10.1590/S0100-879X2006000600013Suche in Google Scholar

3 Donohue, B. A.; Michelotti, E. L.; Reader, J. C.; Reader, V.; Stirling, M.; Tice, C. M.: Design, synthesis, and biological evaluation of a library of 1-(2-Thiazolyl)-5-(trifluoromethyl)pyrazole-4-carboxamides. J. Comb. Chem. 4 (2002) 23–32.10.1021/cc010035aSuche in Google Scholar

4 Khloya, P.; Kumar S.; Kaushik, P.; Surain, P.; Kaushik, D.; Sharma, P. K.: Synthesis and biological evaluation of pyrazolylthiazole carboxylic acids as potent anti-inflammatory–antimicrobial agents. Bioorg. Med. Chem. Lett. 25 (2015) 1177–1181.10.1016/j.bmcl.2015.02.004Suche in Google Scholar

5 Ye, L.; Knapp, J. M.; Sangwung, P.; Fettinger, J. C.; Verkman, A. S.; Kurth, M. J.: Pyrazolylthiazole as ΔF508-cystic fibrosis transmemberane conductance regulator correctors with improved hydrophilicity compared to bithiazoles. J. Med. Chem. 53 (2010) 3772–3781.10.1021/jm100235hSuche in Google Scholar

6 Denisova, A. B.; Sosnovskikh, V. Y.; Dehaen, W.; Toppet, S.; Meervelt, L. V.; Bakulev, V. A.: The regioselectivity of the formation of 2-pyrazolylthiazoles and their precursors from the reaction of 2-hydrazinothiazoles with 4,4,4-trifluoro-1-hetaryl-1,3-butanediones. J. Fluorine Chem. 115 (2002) 183–192.10.1016/S0022-1139(02)00060-XSuche in Google Scholar

7 Abdel-Wahab, B. F.; Mohamed, H. A.; Awad, G. E. A.: Synthesis and antimicrobial activity of some new 3-(4-fluorophenyl)benzo[g]indazoles and 1-pyrazolylthiazoles. Eur. Chem. Bull. 3 (2014) 1069–1074.Suche in Google Scholar

8 Salem, M. E.; Darweesh, A. F.; Mekky, A. E. M.; Farag, A. M.; Elwahy, A. H. M.: 2-Bromo-1-(1H-pyrazol-4-yl)ethanone: versatile precursor for novel mono- and bis [pyrazolylthiazoles]. J. Heterocycl. Chem. 54 (2017) 226–234.10.1002/jhet.2571Suche in Google Scholar

9 Hassan, A. A.; Bebair, T. M.; El-Gamal, M. I.: Synthesis of pyrazolylthiazole and pyrazolyl-1,2,4-triazepine derivatives. J. Chem. Res. 38 (2014) 27–31.10.3184/174751914X13862607015688Suche in Google Scholar

10 Mohamed, H. A.; Abdel-Latif, E.; Abdel-Wahab, B. F.; Awad, G. E. A.: Novel antimicrobial agents: fluorinated 2-(3-(benzofuran-2-yl) pyrazol-1-yl)thiazoles. Int. J. Med. Chem. 2013 (2013) Article ID 986536. doi: 10.1155/2013/986536.10.1155/2013/986536Suche in Google Scholar PubMed PubMed Central

11 El-Hiti, G. A.; Abdel-Wahab, B. F.; Baashen, M.; Ghabbour, H. A.: Crystal structure of 2-(3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-(4-chlorophenyl)thiazole, C26H17ClFN3OS. Z. Kristallogr. - NCS 231 (2016) 911–912.10.1515/ncrs-2016-0004Suche in Google Scholar

12 El-Hiti, G. A.; Abdel-Wahab, B. F.; Ajarim, M. D.; Alobaid, A. M.; Ghabbour, H. A.: Crystal structure of 2-(3-(benzofuran-2-yl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazole, C26H19N3OS. Z. Kristallogr. - NCS 231 (2016) 935–936.10.1515/ncrs-2016-0012Suche in Google Scholar

13 Groom, C. R.; Bruno, I. J.; Lightfoot, M. P.; Ward, S. C.: The Cambridge Structural Database. Acta Crystallogr. B72 (2016) 171–179.10.1016/B978-0-12-409547-2.02529-4Suche in Google Scholar

14 Agilent. CrysAlisPRO. Agilent Technologies, Yarnton, England (2014).Suche in Google Scholar

15 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008). 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

16 Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 45 (2012). 849–854.10.1107/S0021889812029111Suche in Google Scholar

Received: 2016-10-3
Accepted: 2017-2-16
Published Online: 2017-3-18
Published in Print: 2017-5-24

©2017 Gamal A. El-Hiti et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure of 2,5-diiodo-4-nitro-1H-imidazole hemihydrate, C6H4I4N6O5
  3. Crystal structure of catena-poly[μ2-2,2′-(1,3-phenylene)diacetato-κ4O,O′:O′′,O′′′)-(μ2-1,6-bis(2-methyl-1H-benzo[d]imidazol-1-yl)hexane-κ2N:N′)cadmium(II)], C32H34CdN4O4
  4. Crystal structure of poly[aqua-(2,2′-bipyridine-κN,N′)-(μ4-5,5′-(hexane-1,6-diyl)-bis(oxy)diisophthalato κ8O1,O2:O3,O4:O5,O6:O7,O8)manganese(II)], C21H21MnN2O7
  5. Crystal structure of poly-[(μ2-((1,3-bis(benzimidazol-1-yl)propane-κ2N:N′)(μ2-4-tert-butyl-phthalato-κ2O:O′)cobalt(II)] monohydrate, C29H30CoN4O5
  6. Crystal structure of 2-amino-4-(3,4,5-trimethoxy-phenyl)-5-(oxo-5,6,7,8-tetrahydro-4H-chromene)-3-carbonitrile – ethanol (1/1), C21H26N2O6
  7. Crystal structure of ethyl 1-benzyl-5-phenyl-1H-pyrazole-3-carboxylate, C19H18N2O2
  8. Crystal structure of 2-(1-benzyl-3-phenyl-1H-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S
  9. Structure and photochromism of 1,2-bis[2-methyl-5-(2-chlorophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C27H16Cl2F6S2
  10. The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-4-ylmethylene)aniline, C18H22N2
  11. Crystal structure of (E)-2,4-dibromo-6-(((4-methyl-2-nitrophenyl)imino) methyl)phenol, C10H14Br2N2O3
  12. Crystal structure of (bis(2,2′-bipyridine-κ2N,N′))-(3,5-dinitrosalicylato-κ2O,O′)nickel(II), C27H18N6NiO7
  13. Crystal structure of 1-(diethoxy phosphonomethyl) 2-benzoyl-3-chloro-2-cyclohexen-1-ol, C18H24ClO5P
  14. Crystal structure of tetraaqua-bis(1,3-benzimidazol-3-ium-1,3-diacetato-κO)copper(II) hemihydrate, C22H27CuN4O12.50
  15. Crystal structure of 1α,11-dihydroxyeremophil-9-en-8-one, C15H24O3
  16. Crystal structure of 1-ferrocenylsulfonyl-1H-imidazo[4,5-b]pyridine, C16H13FeN3O2S
  17. Crystal structure of bis(μ2-azido-κ2N:N)-dichlorido-bis(μ2-2-(pyridin-2-yl)ethan-1-ol-κ2O,N)dicopper(II), C14H18Cl2Cu2N8O2
  18. Crystal structure of (5,15-cis-bis(2-hydroxy-1-naphthyl)-10-phenyl-20-(4-hydroxyphenyl)-porphyrinato)-(pyridine)-zinc(ii) pyridine solvate, C67H47N7O3Zn
  19. Crystal structure of (μ2-[2,2′-bis(diphenylphosphino)-1,1′-binaphthalene oxide-κ2O,P])-iodido copper(I), C44H32CuIOP2
  20. Crystal structure of 6,8-diphenyl-2-(4-fluorophenyl)-2,3-dihydroquinolin-4(3H)-one, C27H20FNO
  21. Crystal structure of 5,11,17,23-tetra(tert-butyl)-25,26,27,28-tetrahexoxycalix[4]arene, C68H104O4
  22. Crystal structure of N,N′–bis(pyridin-4-ylmethyl)pyrazine-2,3-dicarboxamide dihydrate, C18H20N6O4
  23. Crystal structure of a diaqua-bis(3,5-di(1H-imidazol-1-yl)pyridine-κN)-bis(2-(4-carboxy-phenyl)acetato-κO]manganese(II), C40H36MnN10O10
  24. Crystal structure of 4-(4-hydroxy-3-methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid methyl ester, C21H25NO5
  25. Crystal structure of (E)-4,4′-(ethene-1,2-diyl)bis(3-nitrobenzoic acid) 1.5 hydrate, C16H13N2O9.5
  26. Crystal structure of (E)-2-(5-(4-fluorophenyl)-3-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-5-((4-fluorophenyl)diazenyl)-4-methylthiazole, C23H17F2N5OS
  27. Crystal structure of the co-crystalline adduct 4-((4,4-dimethyl-2,6-dioxocyclohexylidene)methylamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide - acetic acid (1/1), C21H24N4O4S ⋅ C2H4O2
  28. Synthesis and crystal structure of 2-((5-chlorobenzo[c][1,2,5]thiadiazol-4-yl)amino)-4,5-dihydro-1H-imidazol-3-ium tetraphenylborate, C33H29BClN5S
  29. Crystal structure of (4-chlorophenyl)(3-ferrocenyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)methanone, C21H14ClF3FeN2O
  30. Crystal structure of (S)-benzyl 3-(benzylcarba-moyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, C25H24N2O3
  31. Crystal structure of 5-acetyl-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one, C15H17FN2O4
  32. Crystal structure of 2-(4-fluorophenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C19H16FIN2
  33. Crystal structure of methyl 1H-indole-2-carboxylate, C10H9NO2
  34. Crystal structure of 2,3-diphenyl-1-[(dipropylamino)acetyl]-1,3-diazaspiro[4.5]decan-4-one, C28H37N3O2
  35. Crystal structure of 1-(2H-1,3-benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propan-1-one, C13H12N2O3
  36. Crystal structure of 2,9-dibromo-1,10-phenanthroline, C12H6Br2N2
  37. Crystal structure of 3-(adamantan-1-yl)-4-(4-fluorophenyl)-1H-1,2,4-triazole-5(4H)-thione, C18H20FN3S
  38. Crystal structure of trans-bis((E)-7-oxo-4-(phenyldiazenyl)cyclohepta-1,3,5-trien-1-olato)-κ2O,O′)-bis(pyridine-κN)cobalt(II), C36H28CoN6O4
  39. Crystal structure of 2-(4-methyl-3-phenylthiazol-2(3H)-ylidene)malononitrile, C13H9N3S
  40. Crystal structure of (Z)-3-(adamantan-1-yl)-1-(3-chlorophenyl)-S-benzylisothiourea, C24H27ClN2S
  41. Crystal structure of chlorido{[3-(η5-cyclopenta-dienyl)-2,2,3-trimethyl-1-phenylbutylidene] azanido-κN}[η2(N,O)-N,N-dimethylhydroxylaminato]titanium(IV), C20H27ClN2OTi
  42. Crystal Structure of 1,1′-dimethyl-[4,4′-bipyridine]-1,1′-diium tetrachloridozincate(II), C12H14Cl4N2Zn
  43. Crystal structure of 5-nitro-2-(pyrrolidin-1-yl)benzaldehyde, C11H12N2O3
  44. Crystal structure of 2,3-diphenyl-1-(morpholin-4-ylacetyl)-1,3-diazaspiro[4.5]decan-4-one, C26H31N3O3
  45. Crystal structure of 3,3-dimethyl-3,4-dihydro-1H-benzo[c]chromene-1,6(2H)-dione, C15H14O3
  46. Crystal structure of bis(2-(2-hydroxymethyl)pyridine-κ2N,O)-bis(pivalato-κO)nickel(II), C22H32N2NiO6
  47. Crystal structure of (1,10-phenanthroline-κ2N,N′)-bis(1H-pyrazole-3-carboxylato-κ2N,O)manganese(II) trihydrate, C20H20N6O7Mn
  48. The crystal structure of 3-aminopropan-1-aminium iodide, C3H11N2I
  49. Crystal structure of ethyl 1-(4-chlorophenyl)-5-methyl-1H-1,2,3-triazole-4 carboxylate, C12H12ClN3O2
  50. Crystal structure of 4,4′-((1Z,1′Z)-2,2′-(2,5-diethoxy-1,4-phenylene)bis(ethene-2,1-diyl))dipyridine, C24H24N2O2
  51. Crystal structure of (16S)-12,16-epoxy-11,14-dihydroxy-17(15/16)-abeo-3a,18-cyclo-8,11,13-abietatrien-7-one, C20H24O4
  52. Crystal structure of aquadichlorido(2,4,6-tri-2-pyridyl-1,3,5-triazine-κ3N,N′,N′′)nickel(II) monohydrate, C18H16Cl2N6NiO2
  53. Crystal structure of catena-poly[dichlorido-(μ-ethane-1,2-diyl-bis-(pyridyl-4-carboxylate-κN:N′)mercury(II)], C15H14Cl2HgN2O4
  54. Crystal structure of methyl 2-acetamido-5-chlorbenzoate, C10H10ClNO3
  55. Crystal structure of tetrakis(μ2-3,3-dimethylacrylato-κ2O,O′)-bis(2-aminopyrimidine-κN) dicopper(II), C28H38Cu2N6O8
  56. Crystal structure of 3-amino-8-methoxy-1-phenyl-1H-benzo[f]chromene-2-carbonitrile, C21H16N2O2
  57. Crystal structure of 4-(2-ammonioethyl)morpholin-4-ium dichloride monohydrate, C6H18Cl2N2O2
  58. Crystal structure of 1-(3-((5-bromo-2-hydroxybenzylidene)amino)phenyl)ethanone O-benzyl oxime, C22H19BrN2O2
  59. Crystal structure of 2-(4-(dimethylamino)-2-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol monohydrate, C15H20FN7O2
  60. Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O
  61. Crystal structure of 1,2,3,4,5-pentamethyl-1,3-cyclopentadiene, C10H16
https://doi.org/10.1515/ncrs-2016-0293
Creative Commons
BY-NC-ND 3.0

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure of 2,5-diiodo-4-nitro-1H-imidazole hemihydrate, C6H4I4N6O5
  3. Crystal structure of catena-poly[μ2-2,2′-(1,3-phenylene)diacetato-κ4O,O′:O′′,O′′′)-(μ2-1,6-bis(2-methyl-1H-benzo[d]imidazol-1-yl)hexane-κ2N:N′)cadmium(II)], C32H34CdN4O4
  4. Crystal structure of poly[aqua-(2,2′-bipyridine-κN,N′)-(μ4-5,5′-(hexane-1,6-diyl)-bis(oxy)diisophthalato κ8O1,O2:O3,O4:O5,O6:O7,O8)manganese(II)], C21H21MnN2O7
  5. Crystal structure of poly-[(μ2-((1,3-bis(benzimidazol-1-yl)propane-κ2N:N′)(μ2-4-tert-butyl-phthalato-κ2O:O′)cobalt(II)] monohydrate, C29H30CoN4O5
  6. Crystal structure of 2-amino-4-(3,4,5-trimethoxy-phenyl)-5-(oxo-5,6,7,8-tetrahydro-4H-chromene)-3-carbonitrile – ethanol (1/1), C21H26N2O6
  7. Crystal structure of ethyl 1-benzyl-5-phenyl-1H-pyrazole-3-carboxylate, C19H18N2O2
  8. Crystal structure of 2-(1-benzyl-3-phenyl-1H-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S
  9. Structure and photochromism of 1,2-bis[2-methyl-5-(2-chlorophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C27H16Cl2F6S2
  10. The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-4-ylmethylene)aniline, C18H22N2
  11. Crystal structure of (E)-2,4-dibromo-6-(((4-methyl-2-nitrophenyl)imino) methyl)phenol, C10H14Br2N2O3
  12. Crystal structure of (bis(2,2′-bipyridine-κ2N,N′))-(3,5-dinitrosalicylato-κ2O,O′)nickel(II), C27H18N6NiO7
  13. Crystal structure of 1-(diethoxy phosphonomethyl) 2-benzoyl-3-chloro-2-cyclohexen-1-ol, C18H24ClO5P
  14. Crystal structure of tetraaqua-bis(1,3-benzimidazol-3-ium-1,3-diacetato-κO)copper(II) hemihydrate, C22H27CuN4O12.50
  15. Crystal structure of 1α,11-dihydroxyeremophil-9-en-8-one, C15H24O3
  16. Crystal structure of 1-ferrocenylsulfonyl-1H-imidazo[4,5-b]pyridine, C16H13FeN3O2S
  17. Crystal structure of bis(μ2-azido-κ2N:N)-dichlorido-bis(μ2-2-(pyridin-2-yl)ethan-1-ol-κ2O,N)dicopper(II), C14H18Cl2Cu2N8O2
  18. Crystal structure of (5,15-cis-bis(2-hydroxy-1-naphthyl)-10-phenyl-20-(4-hydroxyphenyl)-porphyrinato)-(pyridine)-zinc(ii) pyridine solvate, C67H47N7O3Zn
  19. Crystal structure of (μ2-[2,2′-bis(diphenylphosphino)-1,1′-binaphthalene oxide-κ2O,P])-iodido copper(I), C44H32CuIOP2
  20. Crystal structure of 6,8-diphenyl-2-(4-fluorophenyl)-2,3-dihydroquinolin-4(3H)-one, C27H20FNO
  21. Crystal structure of 5,11,17,23-tetra(tert-butyl)-25,26,27,28-tetrahexoxycalix[4]arene, C68H104O4
  22. Crystal structure of N,N′–bis(pyridin-4-ylmethyl)pyrazine-2,3-dicarboxamide dihydrate, C18H20N6O4
  23. Crystal structure of a diaqua-bis(3,5-di(1H-imidazol-1-yl)pyridine-κN)-bis(2-(4-carboxy-phenyl)acetato-κO]manganese(II), C40H36MnN10O10
  24. Crystal structure of 4-(4-hydroxy-3-methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid methyl ester, C21H25NO5
  25. Crystal structure of (E)-4,4′-(ethene-1,2-diyl)bis(3-nitrobenzoic acid) 1.5 hydrate, C16H13N2O9.5
  26. Crystal structure of (E)-2-(5-(4-fluorophenyl)-3-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-5-((4-fluorophenyl)diazenyl)-4-methylthiazole, C23H17F2N5OS
  27. Crystal structure of the co-crystalline adduct 4-((4,4-dimethyl-2,6-dioxocyclohexylidene)methylamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide - acetic acid (1/1), C21H24N4O4S ⋅ C2H4O2
  28. Synthesis and crystal structure of 2-((5-chlorobenzo[c][1,2,5]thiadiazol-4-yl)amino)-4,5-dihydro-1H-imidazol-3-ium tetraphenylborate, C33H29BClN5S
  29. Crystal structure of (4-chlorophenyl)(3-ferrocenyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)methanone, C21H14ClF3FeN2O
  30. Crystal structure of (S)-benzyl 3-(benzylcarba-moyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, C25H24N2O3
  31. Crystal structure of 5-acetyl-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one, C15H17FN2O4
  32. Crystal structure of 2-(4-fluorophenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C19H16FIN2
  33. Crystal structure of methyl 1H-indole-2-carboxylate, C10H9NO2
  34. Crystal structure of 2,3-diphenyl-1-[(dipropylamino)acetyl]-1,3-diazaspiro[4.5]decan-4-one, C28H37N3O2
  35. Crystal structure of 1-(2H-1,3-benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propan-1-one, C13H12N2O3
  36. Crystal structure of 2,9-dibromo-1,10-phenanthroline, C12H6Br2N2
  37. Crystal structure of 3-(adamantan-1-yl)-4-(4-fluorophenyl)-1H-1,2,4-triazole-5(4H)-thione, C18H20FN3S
  38. Crystal structure of trans-bis((E)-7-oxo-4-(phenyldiazenyl)cyclohepta-1,3,5-trien-1-olato)-κ2O,O′)-bis(pyridine-κN)cobalt(II), C36H28CoN6O4
  39. Crystal structure of 2-(4-methyl-3-phenylthiazol-2(3H)-ylidene)malononitrile, C13H9N3S
  40. Crystal structure of (Z)-3-(adamantan-1-yl)-1-(3-chlorophenyl)-S-benzylisothiourea, C24H27ClN2S
  41. Crystal structure of chlorido{[3-(η5-cyclopenta-dienyl)-2,2,3-trimethyl-1-phenylbutylidene] azanido-κN}[η2(N,O)-N,N-dimethylhydroxylaminato]titanium(IV), C20H27ClN2OTi
  42. Crystal Structure of 1,1′-dimethyl-[4,4′-bipyridine]-1,1′-diium tetrachloridozincate(II), C12H14Cl4N2Zn
  43. Crystal structure of 5-nitro-2-(pyrrolidin-1-yl)benzaldehyde, C11H12N2O3
  44. Crystal structure of 2,3-diphenyl-1-(morpholin-4-ylacetyl)-1,3-diazaspiro[4.5]decan-4-one, C26H31N3O3
  45. Crystal structure of 3,3-dimethyl-3,4-dihydro-1H-benzo[c]chromene-1,6(2H)-dione, C15H14O3
  46. Crystal structure of bis(2-(2-hydroxymethyl)pyridine-κ2N,O)-bis(pivalato-κO)nickel(II), C22H32N2NiO6
  47. Crystal structure of (1,10-phenanthroline-κ2N,N′)-bis(1H-pyrazole-3-carboxylato-κ2N,O)manganese(II) trihydrate, C20H20N6O7Mn
  48. The crystal structure of 3-aminopropan-1-aminium iodide, C3H11N2I
  49. Crystal structure of ethyl 1-(4-chlorophenyl)-5-methyl-1H-1,2,3-triazole-4 carboxylate, C12H12ClN3O2
  50. Crystal structure of 4,4′-((1Z,1′Z)-2,2′-(2,5-diethoxy-1,4-phenylene)bis(ethene-2,1-diyl))dipyridine, C24H24N2O2
  51. Crystal structure of (16S)-12,16-epoxy-11,14-dihydroxy-17(15/16)-abeo-3a,18-cyclo-8,11,13-abietatrien-7-one, C20H24O4
  52. Crystal structure of aquadichlorido(2,4,6-tri-2-pyridyl-1,3,5-triazine-κ3N,N′,N′′)nickel(II) monohydrate, C18H16Cl2N6NiO2
  53. Crystal structure of catena-poly[dichlorido-(μ-ethane-1,2-diyl-bis-(pyridyl-4-carboxylate-κN:N′)mercury(II)], C15H14Cl2HgN2O4
  54. Crystal structure of methyl 2-acetamido-5-chlorbenzoate, C10H10ClNO3
  55. Crystal structure of tetrakis(μ2-3,3-dimethylacrylato-κ2O,O′)-bis(2-aminopyrimidine-κN) dicopper(II), C28H38Cu2N6O8
  56. Crystal structure of 3-amino-8-methoxy-1-phenyl-1H-benzo[f]chromene-2-carbonitrile, C21H16N2O2
  57. Crystal structure of 4-(2-ammonioethyl)morpholin-4-ium dichloride monohydrate, C6H18Cl2N2O2
  58. Crystal structure of 1-(3-((5-bromo-2-hydroxybenzylidene)amino)phenyl)ethanone O-benzyl oxime, C22H19BrN2O2
  59. Crystal structure of 2-(4-(dimethylamino)-2-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol monohydrate, C15H20FN7O2
  60. Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O
  61. Crystal structure of 1,2,3,4,5-pentamethyl-1,3-cyclopentadiene, C10H16
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 1.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2016-0293/html
Button zum nach oben scrollen